WO2005072684A1 - マカ抽出物の製造方法 - Google Patents
マカ抽出物の製造方法 Download PDFInfo
- Publication number
- WO2005072684A1 WO2005072684A1 PCT/JP2005/001201 JP2005001201W WO2005072684A1 WO 2005072684 A1 WO2005072684 A1 WO 2005072684A1 JP 2005001201 W JP2005001201 W JP 2005001201W WO 2005072684 A1 WO2005072684 A1 WO 2005072684A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- ethanol
- extraction
- weight
- food
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 95
- 238000000034 method Methods 0.000 title claims description 12
- 235000000421 Lepidium meyenii Nutrition 0.000 title abstract description 4
- 235000012902 lepidium meyenii Nutrition 0.000 title abstract description 4
- 240000000759 Lepidium meyenii Species 0.000 title abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 86
- 238000000605 extraction Methods 0.000 claims abstract description 46
- 235000013305 food Nutrition 0.000 claims abstract description 36
- 239000002537 cosmetic Substances 0.000 claims abstract description 33
- 230000003266 anti-allergic effect Effects 0.000 claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 25
- 239000007864 aqueous solution Substances 0.000 claims abstract description 14
- 239000000654 additive Substances 0.000 claims description 12
- 235000013361 beverage Nutrition 0.000 claims description 12
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 8
- 229940127557 pharmaceutical product Drugs 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000009508 confectionery Nutrition 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 4
- 235000009973 maize Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 description 30
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 28
- 235000019441 ethanol Nutrition 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000000047 product Substances 0.000 description 22
- 239000002904 solvent Substances 0.000 description 20
- 239000003205 fragrance Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 229960001340 histamine Drugs 0.000 description 14
- -1 stepioside Chemical compound 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 235000013353 coffee beverage Nutrition 0.000 description 5
- 235000021552 granulated sugar Nutrition 0.000 description 5
- 210000003630 histaminocyte Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000043 antiallergic agent Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000554155 Andes Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 229940093625 propylene glycol monostearate Drugs 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000020028 corn beer Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000180 effect on vitality Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 1
- 229960005342 tranilast Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
- A23C9/1544—Non-acidified gels, e.g. custards, creams, desserts, puddings, shakes or foams, containing eggs or thickening or gelling agents other than sugar; Milk products containing natural or microbial polysaccharides, e.g. cellulose or cellulose derivatives; Milk products containing nutrient fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/06—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with flavouring ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Definitions
- the present invention relates to a method for extracting a maize extract obtained from a plant of the Brassicaceae family, and a food or beverage, a cosmetic, or a medicine having an antiallergic effect containing the extract.
- antiallergic agents generally have side effects such as drowsiness, stomach problems, and gastrointestinal disorders, and safety is an issue when taken for a long period of time.
- a number of food materials that are thought to contribute to the treatment of allergic diseases have been searched for.
- Patent Document 1 A throat candy etc. containing an extract has appeared and is used to relieve the symptoms of pollen.
- Miki L-mark idium meyenii Walp
- Ma power is a plant that has been cultivated in the Andes for more than 2,000 years and has been eaten as a food for maintaining health.
- the main components of this power are polysaccharides, proteins, etc., and it contains a lot of amino acids, especially it contains many essential amino acids that cannot be synthesized in the body and need to be taken from food.
- vitamins vitamin B group, C, E, etc.
- minerals calcium, iron, zinc, etc.
- Patent Document 2 Concerning the efficacy of masashi, a composition that has an effect on vitality regeneration, nutrition and tonicity, and has an anticancer action and sexual function improving action has been disclosed (Patent Document 2). Further, there is disclosed a composition having an effect of increasing the concentration of testosterone in humans when used in combination with an antler (Patent Document 3). Furthermore, there is also a report that anti-inflammatory effect of mali is expected as a potential anti-allergic agent (Non-patent Document 4).
- Patent Document 1 JP-A-6-192114
- Patent Document 2 U.S. Patent No. 6267995 B1
- Patent Document 3 JP-T-2003-523945
- Non-patent document 1 Medicine and biology: Vol.145, No.6, p8 86, 2002.12.10
- the present invention applied an effective method for extracting a malay extract having an antiallergic action with excellent safety, which can be taken for a long period of time, and further applied the obtained extract.
- Another object of the present invention is to provide a food or beverage, a cosmetic, or a medicine having an antiallergic effect.
- the present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, surprisingly, the strength of the antiallergic effect of the obtained extract depends on the conditions at the time of extracting power. Was found to have a significant difference in the antiallergic effect, especially when an ethanol-containing aqueous solution was used as the extraction solvent, and when the ethanol concentration of the extract and the temperature of the extraction solvent were within specific ranges.
- the present inventors have found that an extract can be obtained, and have completed the present invention.
- a method for extracting a Ma-ma extract which comprises extracting an aqueous solution containing ethanol into a milled ma-ma extract, wherein the temperature of the extract is 20-75 ° C. Extraction method;
- the present invention provides
- a maize extract having a strong antiallergic effect and suitable for taking orally.
- foods, drinks, cosmetics or pharmaceuticals having an antiallergic effect are provided by including the mash extract or a dried product thereof, and are used for producing such foods, drinks, cosmetics or medicines.
- Additives or distributions A mixture is provided.
- Magi used as a raw material for obtaining an extract according to the method of the present invention is a Brassicaceae plant that grows or grows in the highlands of South America.
- the site used as a raw material for extraction may be any site such as whole grass, flowers, fruits, seeds, stems including rhizomes, bulbs, etc. Among them, the bulb portion is particularly preferably used.
- These raw materials can be pulverized or cut and subjected to extraction as small pieces or powdery pulverized products. If necessary, a drying treatment can be performed. The power extracted in advance with water can also be used.
- the extraction solvent used for obtaining the extract of the power is the power S that can be extracted, and the extract is finally formulated in foods and drinks, etc.
- a water-ethanol mixed aqueous solution ethanol-containing aqueous solution
- the mixing ratio of mash and the solvent in the extraction is not particularly limited, but it is preferable to use about 0.3 to 5,000 times by weight of the solvent with respect to 1 part by weight of the mash. In particular, from the viewpoint of extraction operation and extraction efficiency, it is preferable to use 5 to 100 times by weight.
- the extraction time is not particularly limited. In the conventional example, extraction may take several days or several weeks or more to perform the extraction. , Ranging from 1 minute to 72 hours, especially 10 minutes to 5 An extraction time of about an hour is sufficient.
- the mash extract obtained by intensive force may be extracted as it is, or the concentrated extract from which the solvent of the extract has been removed, or the extract may be dried by freeze-drying or air-drying. It can be used as a dry powder product obtained by the above. From the viewpoints of storage stability and easy portability, it is preferable to use the extract as a concentrated extract or a dry powder product.
- the poultry extract referred to in the present invention refers to these extracts, extract concentrates and dry powder products.
- the present invention also provides foods and drinks, cosmetics, pharmaceuticals, and the like, containing the mah extract obtained therefrom.
- the power itself has been used as a food in Peru since ancient times, and its extract used in the present invention has no problem in terms of safety. Therefore, the blending amount of the mahi extract in the food and drink, cosmetics and pharmaceuticals provided by the present invention is appropriately determined in consideration of its effect, the fragrance and color tone of the product when added. That can be S.
- the strength extract is converted into a concentration range of 0.01 to 99.9%, preferably 0.01 to 99.5% by dry weight.
- the foods and beverages provided by the present invention include candy, troche, gum, gnogoreto, ice cream, pudding, jelly, water yokan, alcoholic drink, coffee drink, juice, fruit juice drink, carbonated drink, soft drink, milk And various beverages such as whey drink, lactic acid bacteria drink and the like.
- These foods and drinks can be mixed with various additives as necessary, and can be prepared according to a conventional method. Specifically, when preparing these foods and drinks, for example, glucose, fructose, sucrose, maltose, sorbitol, stepioside, rubusoside, corn syrup, lactose, citric acid, tartaric acid, malic acid, succinic acid, lactic acid , L-ascorbic acid, dl-heart tocophenol, sodium erysorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan Fatty acid esters, propylene glycol fatty acid esters, gum arabic, carrageenan, casein, gelatin, pectin, agar, vitamins B, nicotinamide, pantothenic acid, potassium, amino acids, calcium salts, pigments, flavors, preservatives, etc. It can
- the cosmetics provided by the present invention are products called cosmetics and fragrance products.
- non-oral cosmetics such as lotions, makeup creams, milky lotions, foundations, lipsticks, hairdressing products, hair tonics, hair growth products, shampoos, rinses, bath salts, toothpastes, mouthwashes, mouthwashes, oral cavity
- the desired cosmetics can be prepared by adding an appropriate amount of mahi extract to oral cosmetics such as fragrances.
- oils and fats such as vegetable oils, waxes such as lanolin and beeswax, hydrocarbons, fatty acids, higher alcohols and esters, various surfactants, pigments, fragrances, It can be obtained according to a conventional method by appropriately mixing vitamins, plant / animal extract components, ultraviolet absorbers, antioxidants, preservatives / bactericides, etc., which are commonly used as cosmetic ingredients.
- the pharmaceutical product when preparing the pharmaceutical product provided by the present invention, it is possible to mix various additives as necessary and further contain an appropriate amount of the ma extract to prepare the pharmaceutical product in various dosage forms. it can.
- oral medicines such as tablets, capsules, granules, powders, syrups IJ, extracts, or ointments, eye ointments, lotions, creams, patches, suppositories, eye drops, nasal drops, injections As a parenteral drug.
- These pharmaceuticals may be manufactured using various additives according to a conventional method.
- additives include solid carriers such as starch, lactose, sucrose, mannitol, carboxymethylcellulose, corn starch, and inorganic salts; Water, physiological saline, aqueous glucose solution, alcohols such as ethanol, liquid carriers such as propylene glycol, polyethylene glycol and the like; various animal and vegetable oils, oil carriers such as white petrolatum, paraffin, waxes and the like.
- the mash extract provided by the present invention has an antiallergic effect and is also excellent in safety when taken orally. Therefore, it is used in foods and drinks, oral pharmaceuticals, and oral cosmetics. Can be suitably used.
- the daily amount and dosage of the power extract There are no particular restrictions on the daily amount and dosage of the power extract.
- the additive or combination for food and drink, cosmetics and pharmaceuticals in the present invention refers to foods and beverages, cosmetics and pharmaceuticals such as fragrances, dyes and antioxidants. It is a mixture of a commonly used additive or compounding agent and mah extract. The mixing ratio may be appropriately set according to the purpose.
- the additives or compounding agents for foods and drinks, cosmetics or pharmaceuticals used herein the various additives described above can be mentioned.
- the anti-allergic effect of the macha extract provided by the present invention can be evaluated using the effect of suppressing the release of histamine from mast cells as an index.
- R the amount of histamine released from cells when an inducer is added
- SR The amount of histamine released from the cells when a trigger is added in the presence of a sample.
- the extract thus obtained was filtered, and the filtrate was freeze-dried to obtain the product of the present invention.
- Each of the obtained invention products was used as a 0.25 mg / mL solution, and the effect of inhibiting histamine release from the above mast cells was evaluated.
- the histamine of invention 19 obtained when the ethanol concentration of the extraction solvent was 20-100% and the extraction temperature was in the range of 20-75 ° C. In the case of production of free control, all were stronger than the control products 1-3. The same was true for Inventions 10 and 11, which used mah residue obtained by pre-extracting the mah water and treating it.
- Invention 2-5 in which the extraction temperature of the extraction solution was 60 ° C and the ethanol concentration was 45-100%, and the extraction temperature of the extraction solvent was 40 ° C, and the ethanol concentration was 60%.
- Inventive product 6 obtained as above had a histamine release inhibitory activity of 5683%, indicating a strong antiallergic effect. This was stronger than the histamine release inhibitory effect (50%) of DSCG (0.1 mg / mL) evaluated in the same test system.
- Production Example 1 Pharmaceutical product containing malayu yuzu tablet:
- compositions (tablets) containing the mah extract were produced by the following method. 3 kg of dried and pulverized mahiki was placed in a stainless steel container, and 30 L of an aqueous solution containing 99% by volume of ethanol was added thereto and stirred at 60 ° C for 3 hours. The solution was collected by filtration, and the solvent was removed from the obtained extract to obtain 180 g of a mahi extract.
- composition shown below various foods and drinks containing the malay extract were produced.
- composition (parts by weight)
- composition (parts by weight)
- composition (parts by weight) Gum base 20.0 Calcium carbonate 2.0 Stevioside 0.1 Power extract 0.05 Lactose 76.85 m. L_Q_ Total amount 100.00
- composition (parts by weight) Granulated sugar 32.0 starch syrup 20.0 powdered milk 40.0 hardened oil 4.0 salt 0.6 flavoring 0.02 Water 3.22 Mali Yuzu product 0.16 Total 100.00
- Jelly (coffee jelly):
- composition (Parts by weight) Granulated sugar 15.0 Gelatin 1.0 Coffee extract 5.0 Water 78.93 Water extract 0.77 Total amount 100.00
- composition (Parts by weight) Fresh cream (45% fat) 33 ⁇ 8 Skim milk powder 11.0 Granulated sugar 14.8 Sugared egg yolk 0.3 Vanilla essence 0.1 Water 39.93 Ma-yuzu extract 0.07 Whole amount 100. 00
- composition (Parts by weight) Milk 47.51 Whole egg 31.9 Shirasu sugar 17.1 Water 3.4 Ma-yuzu product 0.09 100. 00
- Granulated sugar 8.0 Concentrated lemon juice 1.0 L L-asconolevic acid 0.10 Cuenoic acid 0.09 Sodium citrate 0.05 Coloring
- composition (parts by weight) Granulated sugar 8.0 Skim milk powder 5.0 Caramenole 0.2 Coffee extract 2.0 Flavor 0.1 Polyglycerin fatty acid. Estenole 0.
- composition (parts by weight)
- composition (parts by weight)
- composition (parts by weight)
- Emollient cream [0057] Emollient cream:
- composition (parts by weight) Stearic acid 2.0 Cetanol 1.5 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin
- Emulsion foundation [0059] Emulsion foundation:
- composition (parts by weight)
- Stearic acid 2.4 Propylene glycol monostearate 2.0 Cetostearyl alcohol 0.2 Liquid lanolin 2.0 Liquid paraffin 3.0 Isopropyl myristate 8.5 Propyl parahydroxybenzoate Trace amount Purified water 64.1 Sodium carboxymethyl cellulose 0 2 Bentonite 0.5 Propylene glycosole 3.8 Sodium hyaluronate 0.1 Power extract 0.1 Triethanolamine 1.1 Methyl parahydroxybenzoate Trace titanium oxide 8.0 Talc 4.0 Color content Trace fragrance Trace Total 100.0
- Tonic for hair growth (Composition) (Parts by weight) Ethanol
- composition (parts by weight)
- the extraction method of the present invention provides a virgin extract having a strong antiallergic effect. Since the obtained Maji extract has strong anti-allergic activity, foods, beverages, cosmetics or pharmaceuticals containing it are extremely effective for patients with allergic diseases, Its industrial contribution is enormous in that it can suppress the development of allergic symptoms in daily life.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/587,522 US20070280975A1 (en) | 2004-01-28 | 2005-01-28 | Method for Producing Maca Extract |
EP05709428A EP1714635A1 (en) | 2004-01-28 | 2005-01-28 | Process for producing maca extract |
JP2005517506A JPWO2005072684A1 (ja) | 2004-01-28 | 2005-01-28 | マカ抽出物の製造方法 |
CA002553987A CA2553987A1 (en) | 2004-01-28 | 2005-01-28 | Method for producing maca extract |
AU2005207718A AU2005207718A1 (en) | 2004-01-28 | 2005-01-28 | Process for producing Maca extract |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-019283 | 2004-01-28 | ||
JP2004019283 | 2004-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005072684A1 true WO2005072684A1 (ja) | 2005-08-11 |
Family
ID=34823710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/001201 WO2005072684A1 (ja) | 2004-01-28 | 2005-01-28 | マカ抽出物の製造方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070280975A1 (ja) |
EP (1) | EP1714635A1 (ja) |
JP (1) | JPWO2005072684A1 (ja) |
KR (1) | KR20060128964A (ja) |
CN (1) | CN1909881A (ja) |
AU (1) | AU2005207718A1 (ja) |
CA (1) | CA2553987A1 (ja) |
TW (1) | TW200529864A (ja) |
WO (1) | WO2005072684A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006204210A (ja) * | 2005-01-28 | 2006-08-10 | Towa Corporation 株式会社 | ベンジルグルコシノレート含有組成物、その呈味改善方法およびベンジルグルコシノレート含有飲料物 |
JP2007097545A (ja) * | 2005-10-07 | 2007-04-19 | Suntory Ltd | 酢酸又は食酢を配合したマカ抽出物含有飲食物 |
JP2007290969A (ja) * | 2006-04-21 | 2007-11-08 | Nippon Menaade Keshohin Kk | 抗ストレス組成物 |
KR100814133B1 (ko) | 2006-12-05 | 2008-03-18 | 주식회사 내추럴하우스 | 마카마이드 고 함유 마카 추출물 제조방법 |
JP2013501778A (ja) * | 2009-08-11 | 2013-01-17 | ヨン ジン キム | チアシード及びマカを含む健康補助食品、飼料、薬学組成物並びにその製造方法 |
KR101785348B1 (ko) | 2016-05-25 | 2017-10-17 | 남광섭 | 흑마늘과 흑마카 혼합 추출엑기스의 제조방법 |
JP2022184813A (ja) * | 2021-05-31 | 2022-12-13 | 高雄醫學大學 | マカ抽出物及びその用途 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101017315B1 (ko) * | 2007-07-18 | 2011-02-28 | 주식회사 이스터비엔에프 | 발효 마카 조성물 및 그 제조 방법 |
TWI383754B (zh) * | 2008-07-18 | 2013-02-01 | Tci Co Ltd | 食品錠劑 |
BR112012004791A2 (pt) * | 2009-09-04 | 2017-07-18 | Vago Andras | dispositivo de acesso multifuncional personalizado com forma individualizada de autenticar e controlar a troca de dados. |
CN101816365A (zh) * | 2010-04-30 | 2010-09-01 | 云南瑞升烟草技术(集团)有限公司 | 一种玛咖糖果 |
ITVA20100074A1 (it) * | 2010-10-11 | 2012-04-12 | Cinzia Maiuri | Composizione cosmeceutica riepitelizzante, anti-aging, antiossidante, antiradicali liberi e/o igienizzante dell' apparato buccale. |
FR2969495B1 (fr) * | 2010-12-22 | 2013-10-11 | Expanscience Lab | Extrait de parties aeriennes de maca riche en polyphenols et composition le comprenant |
CN102551066A (zh) * | 2012-03-26 | 2012-07-11 | 张丽琴 | 玛咖虫草松露保健食品 |
CN102579547A (zh) * | 2012-03-26 | 2012-07-18 | 张丽琴 | 玛咖有效成分的提取方法 |
CN102697039A (zh) * | 2012-05-31 | 2012-10-03 | 昆明理工大学 | 一种玛卡活性萃取物的制备方法 |
CN104513173B (zh) * | 2013-09-30 | 2018-03-06 | 中国科学院过程工程研究所 | 一种玛咖提取物、其制备方法及其用途 |
CN104146250B (zh) * | 2014-08-02 | 2016-01-20 | 昆明骊玛生物科技有限公司 | 一种玛咖组合物的制备方法及其应用 |
CN104207134B (zh) * | 2014-10-11 | 2016-05-11 | 王衍彬 | 一种玛咖提取物的制备方法 |
WO2017155515A1 (en) * | 2016-03-08 | 2017-09-14 | MANSOUR, Mariam, Awadh | Herbal sonicated e-nano e-liquid mix for zero-nicotine e-cigarette for improving smoker's health |
WO2018057895A1 (en) * | 2016-09-23 | 2018-03-29 | Smoothie Beauty, Inc. | Cosmetic compositions comprising food-grade components and methods of making and using same |
CN111093619A (zh) * | 2018-08-02 | 2020-05-01 | 安帝芭株式会社 | 男性清洁剂及其制备方法 |
CN111083923A (zh) * | 2018-08-20 | 2020-04-28 | 安帝芭株式会社 | 舒缓霜以及其制造方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0812565A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | 皮膚外用剤 |
WO2000051548A2 (en) * | 1999-03-03 | 2000-09-08 | Pure World Botanicals, Inc. | COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) |
JP2001039854A (ja) * | 1999-07-30 | 2001-02-13 | Sanko Bussan Kk | 皮膚外用剤 |
JP2002161043A (ja) * | 2000-11-27 | 2002-06-04 | Ts Aasu:Kk | 皮膚外用剤 |
JP2004000171A (ja) * | 2002-03-22 | 2004-01-08 | Towa Corp | マカを含有した機能性食品 |
-
2005
- 2005-01-27 TW TW094102402A patent/TW200529864A/zh unknown
- 2005-01-28 AU AU2005207718A patent/AU2005207718A1/en not_active Abandoned
- 2005-01-28 CA CA002553987A patent/CA2553987A1/en not_active Abandoned
- 2005-01-28 US US10/587,522 patent/US20070280975A1/en not_active Abandoned
- 2005-01-28 WO PCT/JP2005/001201 patent/WO2005072684A1/ja active Application Filing
- 2005-01-28 KR KR1020067015187A patent/KR20060128964A/ko not_active Application Discontinuation
- 2005-01-28 EP EP05709428A patent/EP1714635A1/en not_active Withdrawn
- 2005-01-28 JP JP2005517506A patent/JPWO2005072684A1/ja active Pending
- 2005-01-28 CN CNA200580002835XA patent/CN1909881A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0812565A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | 皮膚外用剤 |
WO2000051548A2 (en) * | 1999-03-03 | 2000-09-08 | Pure World Botanicals, Inc. | COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) |
JP2001039854A (ja) * | 1999-07-30 | 2001-02-13 | Sanko Bussan Kk | 皮膚外用剤 |
JP2002161043A (ja) * | 2000-11-27 | 2002-06-04 | Ts Aasu:Kk | 皮膚外用剤 |
JP2004000171A (ja) * | 2002-03-22 | 2004-01-08 | Towa Corp | マカを含有した機能性食品 |
Non-Patent Citations (2)
Title |
---|
MATSUMOTO Y. ET AL: "Maka (Lepidium meyennii Walp) no Ko-Allergy Kassei.", NIPPON YAKUGAKUKAI NENKAI KOEN YOSHISHU., vol. 124, no. 2, 5 March 2004 (2004-03-05), pages 113, XP002991206 * |
SUZUKI I. ET AL: "Maka Chushutsubutsu no Rat Sokusei Fushu ni Taisuru Koensho Sayo.", MEDICINE AND BIOLOGY., vol. 145, no. 6, 10 December 2002 (2002-12-10), pages 81 - 86, XP002991205 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006204210A (ja) * | 2005-01-28 | 2006-08-10 | Towa Corporation 株式会社 | ベンジルグルコシノレート含有組成物、その呈味改善方法およびベンジルグルコシノレート含有飲料物 |
JP2007097545A (ja) * | 2005-10-07 | 2007-04-19 | Suntory Ltd | 酢酸又は食酢を配合したマカ抽出物含有飲食物 |
JP4627477B2 (ja) * | 2005-10-07 | 2011-02-09 | サントリーホールディングス株式会社 | 酢酸又は食酢を配合したマカ抽出物含有飲食物 |
JP2007290969A (ja) * | 2006-04-21 | 2007-11-08 | Nippon Menaade Keshohin Kk | 抗ストレス組成物 |
KR100814133B1 (ko) | 2006-12-05 | 2008-03-18 | 주식회사 내추럴하우스 | 마카마이드 고 함유 마카 추출물 제조방법 |
JP2013501778A (ja) * | 2009-08-11 | 2013-01-17 | ヨン ジン キム | チアシード及びマカを含む健康補助食品、飼料、薬学組成物並びにその製造方法 |
KR101785348B1 (ko) | 2016-05-25 | 2017-10-17 | 남광섭 | 흑마늘과 흑마카 혼합 추출엑기스의 제조방법 |
JP2022184813A (ja) * | 2021-05-31 | 2022-12-13 | 高雄醫學大學 | マカ抽出物及びその用途 |
JP7446003B2 (ja) | 2021-05-31 | 2024-03-08 | 高雄醫學大學 | マカ抽出物及びその用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1909881A (zh) | 2007-02-07 |
EP1714635A1 (en) | 2006-10-25 |
CA2553987A1 (en) | 2005-08-11 |
TW200529864A (en) | 2005-09-16 |
US20070280975A1 (en) | 2007-12-06 |
KR20060128964A (ko) | 2006-12-14 |
JPWO2005072684A1 (ja) | 2007-09-06 |
AU2005207718A1 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005072684A1 (ja) | マカ抽出物の製造方法 | |
JP5207611B2 (ja) | 糖化阻害剤 | |
US20090269424A1 (en) | Peripheral blood flow-improving composition | |
JP3768795B2 (ja) | キサンチンオキシダーゼ阻害剤 | |
KR102153414B1 (ko) | 약콩 발효물을 포함하는 탈모 개선 및 발모 촉진용 조성물 | |
JP2700958B2 (ja) | 甜茶抽出物を有効成分とする医薬並びにこれを配合した食品および化粧品 | |
KR101889793B1 (ko) | 수산동물 발효물을 포함하는 탈모 방지 및 육모 촉진을 위한 조성물 | |
JP3241609B2 (ja) | 甜茶抽出物を有効成分とする医薬並びにこれを配合した食品および化粧品 | |
KR20200140749A (ko) | 꾸지뽕나무를 유효성분으로 함유하는 근육 질환 개선, 치료 또는 예방용, 또는 근 기능 개선용 조성물 | |
JP6964290B2 (ja) | Atp産生促進用剤 | |
JP5403320B2 (ja) | 天然抽出物より得られた脱顆粒抑制剤、β−ヘキソサミニダーゼ遊離抑制剤、抗アレルギー剤および抗炎症剤 | |
JP3241610B2 (ja) | 甜茶抽出物を有効成分とする医薬並びにこれを配合した食品および化粧品 | |
KR102283946B1 (ko) | 유자 유래 항염증 화합물 및 이의 분리방법 | |
KR20230064936A (ko) | 푸른여로 추출물을 이용한 발모 촉진 또는 탈모 억제용 조성물 | |
WO2005094859A1 (ja) | 皮膚保湿能改善剤 | |
JP5370996B2 (ja) | リパーゼ阻害剤 | |
KR20220048640A (ko) | 항염증 면역활성 및 항산화 활성을 가지며, 노인의 근력 또는 근육 강화를 위한 근세포 조성에 우수한 효과를 제공하는 프테로카리아 스테놉테라 추출물을 포함하는 화장료 조성물, 약학적 조성물, 및 식품 조성물 | |
KR101829514B1 (ko) | 줄의관말 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
KR20200083146A (ko) | 팔각회향 또는 시킴산을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
JP2019182863A (ja) | 肌のハリ又はうるおいの改善用組成物 | |
KR101609436B1 (ko) | 갈고리가시우무 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
KR102633488B1 (ko) | 배초향 추출물 또는 틸리아닌를 유효성분으로 함유하는 근육 질환 개선, 치료 또는 예방용, 또는 근 기능 개선용 조성물 | |
KR102465346B1 (ko) | 구절초 및 꾸지뽕 복합 추출물을 유효성분으로 포함하는 항염증 조성물 | |
KR102117547B1 (ko) | 필레아 마티니 추출물을 포함하는 염증성 질환 예방 또는 치료용 조성물 | |
JP6928337B2 (ja) | No産生抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005517506 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2553987 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580002835.X Country of ref document: CN Ref document number: 2005207718 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067015187 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005207718 Country of ref document: AU Date of ref document: 20050128 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005207718 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005709428 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005709428 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067015187 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10587522 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10587522 Country of ref document: US |